Update Membership Claim dcbtnnext dcbtnPrevious dcbtnnext_h dcbtnPrevious_h L_ pmarker dcwatermark

Professional Statement

  • Ryan B. Turner, M.D. is a board certified dermatologist in New York City who practices general dermatology and has advanced training in Mohs Micrographic Surgery, laser surgery, and light therapies. His clinical interests include skin cancer surgery and cosmetic treatments that enhance and rejuvenate aging skin. He has extensive training in laser resurfacing treatments which reduce photodamage, wrinkles, and stimulate new collagen growth. His research interests vary from the treatment and management of skin cancers to the successful placement of injectable dermal fillers. He graduated summa cum laude and valedictorian of the University of Maryland Baltimore County. He received his Doctor of Medicine from Harvard Medical School and was honored with the Henry Asbury Christian Award for his research accomplishments at graduation. He completed his internship in medicine and his dermatology residency at the Harvard affiliated Brigham and Women’s Hospital and the Massachusetts General Hospital, respectively. He has also completed an ACGME accredited fellowship in Procedural Dermatology at the Mount Sinai Medical Center in New York.

Education & Training

  • Medical School - Harvard University
  • Icahn School of Medicine at Mount Sinai, Fellowship in Mohs Surgery
  • Massachusetts General Hospital, Residency in Dermatology
  • Brigham and Women's Hospital, Internship in Internal Medicine

Board Certifications

  • American Board of Dermatology

Awards and Publications

  • Henry Asbury Christian Award (Harvard Medical Graduation Honors)
  • Daniel C. Toteson, M.D. Scholarship
  • Howard Hughes Medical Student Fellow Continuation Award
  • Howard Hughes Medical Student Fellow
  • National Heart, Lung and Blood Institute (NHLBI) Supplement Awardee
  • Turner RB, Smith DL, Zawrotny ME, Summers MF, Posewitz MC, Winge DR. Solution structure of a zinc domain conserved in yeast copper-regulated transcription factors. Nat Struct Biol. 1998 Jul;5(7):551-5.
  • Amarasinghe GK, De Guzman RN, Turner RB, Summers MF. NMR structure of stem-loop SL2 of the HIV-1 psi RNA packaging signal reveals a novel A-U-A base-triple platform. J Mol Biol. 2000 May 26;299(1):145-56.
  • Johnson PE, Turner RB, Wu ZR, Hairston L, Guo J, Levin JG, Summers MF. A mechanism for plus-strand transfer enhancement by the HIV-1 nucleocapsid protein during reverse transcription. Biochemistry. 2000 Aug 8;39(31):9084-91.
  • Amarasinghe GK, De Guzman RN, Turner RB, Chancellor KJ, Wu ZR, Summers MF. NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J Mol Biol. 2000 Aug 11;301(2):491-511.
  • Liu L, Sazonova IY, Turner RB, Chowdhry SA, Tsai J, Houng AK, Reed GL. Leucine 42 in the fibronectin motif of streptokinase plays a critical role in fibrin-independent plasminogen activation. J Biol Chem. 2000 Dec 1;275(48):37686-91.
  • Gladysheva IP, Sazonova IY, Chowdhry SA, Liu L, Turner RB, Reed GL. Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactions. J Biol Chem. 2002 Jul 26;277(30):26846-51.
  • Turner RB, Liu L, Sazonova IY, Reed GL. Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin. J Biol Chem. 2002 Sep 6;277(36):33068-74.
  • Gladysheva IP, Turner RB, Sazonova IY, Liu L, Reed GL. Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9168-72.
  • Wilkins K, Turner R, Dolev JC, LeBoit PE, Berger TG, Maurer TA. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol. 2006 Feb;54(2):189-206

Professional Memberships

  • American Academy of Dermatology
  • American Society for Dermatologic Surgery
  • American College of Mohs Surgery

Language Spoken

  • English